← Open Payments lookup

IAN CHIU: Open Payments

NPI 1477147585 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$12,094 in 43 payments from 13 companies in 2025. Trend: 2023 $549 · 2024 $1,532 · 2025 $12,094

Speaker / faculty: $4,125Consulting: $4,046Food & beverage: $2,029Travel & lodging: $1,894
CompanyPaymentsAmount
Amgen Inc.12$5,727
Apellis Pharmaceuticals, Inc.6$4,993
Travere Therapeutics, Inc.6$506
Alexion Pharmaceuticals, Inc.3$185
Novartis Pharmaceuticals Corporation3$174
Aurinia Pharma U.S., Inc.1$149
Otsuka Pharmaceutical Development & Commercialization, Inc.1$125
Calliditas Therapeutics US Inc.3$86
Otsuka America Pharmaceutical, Inc.2$47
GlaxoSmithKline, LLC.3$42

Products named: TAVNEOS, Filspari, ULTOMIRIS, UPLIZNA, Vanrafia, LUPKYNIS, TARPEYO, BENLYSTA.

Industry payments across NY — which companies pay providers there.